Glucocorticoids Inhibit IRF3 Phosphorylation in Response to Toll-like Receptor-3 and -4 by Targeting TBK1 Activation
Claire E. McCoy(Royal College of Surgeons in Ireland), Luke O'neill(Trinity College Dublin)
Cited by 81
Related Papers
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
|Cell Research|2015|1.8k
Targeting Toll-like receptors: emerging therapeutics?
|Nature Reviews Drug Discovery|2010|883
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
|Cell Metabolism|2020|571
Targeting immunometabolism as an anti-inflammatory strategy
|Cell Research|2020|552
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
|Pharmacological Reviews|2009|422